Clinical Impact of Two Different Diagnostic Strategies in the First- and Second-Line Treatment of Locally Advanced or Metastatic EGFR-Mutated Non-Small Cell Lung Cancer. FE 2020, 21 (1). https://doi.org/10.7175/fe.v21i1.1450.